Evaluation of Safety of Cabazitaxel (Jevtana) in Patients With Metastatic Hormone Refractory Prostate Cancer
Clinical trial NCT02074137 · COMPLETED
Trial details
- NCT number
- NCT02074137
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2016-03-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.